IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study

Background: Stem cell transplantation is emerging as a potential therapeutic strategy in several autoimmune diseases. However, the safety and feasibility of long-term combined intravenous (IV) and intrathecal (IT) administration of hUC-MSCs in relapse remitting multiple sclerosis (RRMS) and neuromye...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Zhengjuan, Zhu, Lin, Liu, Zhuo, Wu, Jiayong, Xu, Yun, Zhang, Cun-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506071/
https://www.ncbi.nlm.nih.gov/pubmed/33013641
http://dx.doi.org/10.3389/fneur.2020.00967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506071/
https://www.ncbi.nlm.nih.gov/pubmed/33013641
http://dx.doi.org/10.3389/fneur.2020.00967

Ejemplares similares